Clinical Toxicology Service, Guy's and St. Thomas' NHS Foundation Trust and King's Health Partners and King's College London, London, UK.
J Med Toxicol. 2012 Sep;8(3):295-9. doi: 10.1007/s13181-012-0240-4.
Until recently, there were limited data available on the epidemiology of recreational drug use in the Asia Pacific region. However, in the last few years, a number of United Nations Office on Drugs and Crime (UNODC) programmes have improved data collection networks, particularly in East and Southeast Asia. There are still significant data gaps from some countries, including India and China, and data reported from some countries in the region are based on expert estimates on recreational drug use rather than formally collected data. However, the availability of improved epidemiological data has enabled many countries in the region, both individually and through regional UNODC programmes, to start to understand the issues that need to be addressed. We will summarise in this mini-review the data available within the UNODC World Drug Report and from the other UNODC programmes in the region on the production and use of recreational drugs in the Asia Pacific region.
直到最近,亚太地区娱乐性药物使用的流行病学数据还很有限。然而,在过去几年中,联合国毒品和犯罪问题办公室(UNODC)的一些方案已经改善了数据收集网络,特别是在东亚和东南亚。包括印度和中国在内的一些国家仍然存在重大的数据空白,该地区一些国家报告的数据是基于对娱乐性药物使用的专家估计,而不是正式收集的数据。然而,流行病学数据的可用性使该地区许多国家,无论是单独还是通过区域 UNODC 方案,都开始了解需要解决的问题。我们将在这篇简评中总结 UNODC《世界毒品报告》和该地区其他 UNODC 方案中提供的关于亚太地区娱乐性药物生产和使用的现有数据。